Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Long-Term Deferred Tax (2018 - 2024)

OptimizeRx's Long-Term Deferred Tax history spans 7 years, with the latest figure at $4.5 million for Q4 2024.

  • On a quarterly basis, Long-Term Deferred Tax rose 3.55% to $4.5 million in Q4 2024 year-over-year; TTM through Dec 2024 was $4.5 million, a 3.55% increase, with the full-year FY2024 number at $4.5 million, up 3.55% from a year prior.
  • Long-Term Deferred Tax hit $4.5 million in Q4 2024 for OptimizeRx, up from $4.3 million in the prior quarter.
  • Over the last five years, Long-Term Deferred Tax for OPRX hit a ceiling of $10.5 million in Q4 2022 and a floor of $4.3 million in Q4 2023.
  • Historically, Long-Term Deferred Tax has averaged $5.8 million across 5 years, with a median of $4.5 million in 2020.
  • Biggest five-year swings in Long-Term Deferred Tax: skyrocketed 99.39% in 2022 and later tumbled 58.66% in 2023.
  • Tracing OPRX's Long-Term Deferred Tax over 5 years: stood at $4.5 million in 2020, then increased by 15.7% to $5.3 million in 2021, then skyrocketed by 99.39% to $10.5 million in 2022, then tumbled by 58.66% to $4.3 million in 2023, then grew by 3.55% to $4.5 million in 2024.
  • Business Quant data shows Long-Term Deferred Tax for OPRX at $4.5 million in Q4 2024, $4.3 million in Q4 2023, and $10.5 million in Q4 2022.